Metabolic and liver health
Clinical questions around metabolic dysfunction-associated steatotic liver disease (MASLD), diabetes, obesity and the practical management of related cardiometabolic risk.
Research and academic contributions
Dr. Kulwant Yadav is committed to advancing medical science and improving patient outcomes through clinically relevant research. His academic work connects evidence-based Internal Medicine, critical-care interventions and the cardiovascular and hepatic implications of metabolic disease.

Research profile
Clinical research is most useful when it answers a meaningful question: how a treatment performs in routine practice, how a high-risk procedure can be safer, or how connected metabolic factors affect long-term health. Dr. Yadav's work is shaped by those questions.
This page brings together current research activity, peer-reviewed publications and postgraduate academic work. It is intended for patients, colleagues and collaborators who would like to understand the academic interests that inform his wider clinical perspective.
Areas of interest
Clinical questions around metabolic dysfunction-associated steatotic liver disease (MASLD), diabetes, obesity and the practical management of related cardiometabolic risk.
Evidence-based approaches to acute care, airway management and safer, resource-conscious interventions in intensive-care settings.
The relationship between metabolic disease, body composition and structural or functional changes in cardiovascular health.
Ongoing clinical research
A real-world evidence study examining Saroglitazar 4 mg in female patients with metabolic dysfunction-associated steatotic liver disease.
This active multicentre, retrospective observational study is designed to understand treatment effectiveness in routine clinical practice. Its clinical focus is the evaluation of changes related to liver fat and fibrosis in women with MASLD, alongside the broader metabolic context in which the condition is managed.
Peer-reviewed publications
Critical care · 2025
International Journal of Critical Illness and Injury Science. 2025;15(4):157–162.
This publication examines an innovative and cost-conscious approach to percutaneous tracheostomy, with relevance for critical-care teams working in resource-limited intensive-care settings.
Read the publication on PubMed Central ↗Cardiovascular critical care · 2023
Journal of Cardiovascular Disease Research. 2023.
This clinical case study focuses on recognising and managing an uncommon but life-threatening complication during a routinely performed critical-care procedure.
Read the publication in the journal ↗Academic thesis

This postgraduate study explores the intersection of type 2 diabetes, body composition and cardiovascular health. It considers how metabolic syndrome and lifestyle-related risk factors may relate to structural heart changes identified through echocardiography.
Its central theme remains highly relevant to modern Internal Medicine: metabolic disease is rarely confined to one organ system, and meaningful assessment often requires attention to the connected health of the heart, liver, kidneys and wider cardiovascular system.
Academic activity complements, rather than replaces, individual clinical assessment. Treatment and investigation decisions are always based on a patient's symptoms, examination, history, investigations and clinical judgement.